Nothing new here and no mention of the clinical trial which would be in April and findings published in June which Andreas mentioned in his last webinar.
They seem to be moving at a snails pace and at present do not have any hospitals actually willing to on board, not even Monash where the technology was pioneered.
It has TGA and FDA approval, surely one hospital would be happy to start using it with minimal trials given it has regulatory approval?
Sure you would still assess progress closely for the first 3-6 months but I don't think there needs to be these excessive clinical trials.
Ann: 4DMedical Goldman Sachs Healthcare Forum Presentation, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
52.5¢ |
Change
-0.005(0.94%) |
Mkt cap ! $215.4M | |||
| Open | High | Low | Value | Volume |
| 52.5¢ | 53.0¢ | 51.5¢ | $146.0K | 279.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 21156 | 52.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 310 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |